1. FLECKENSTEIN, A.: Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: Calcium and the Heart, HARRIS, P., OPIE, L. (Eds.) London-New York: Academic Press 1970/1971a, pp. 135–188.
2. FLECKENSTEIN, A.: Neuere Ergebnisse zur Physiologie, Pharmakologie und Pathologie der elektromechanischen Koppelungsprozesse im Warmblütermyokard. In: Vorträge der Erlanger Physiologentagung 1970. KEIDEL, W.D., PLATTIG, K.-H. (Eds.) Berlin-Heidelberg-New York: Springer 1970/1971b, pp. 13–52.
3. FLECKENSTEIN, A., BYON, K.Y.: Prevention by Ca-antagonistic compounds (verapamil, D 600) of coronary smooth muscle contractures due to treatment with cardiac glycosides. Naunyn-Schmiedeberg’s Arch. Pharmacol. 282, Suppl. R 20 (1974).
4. Handb. exper. Pharmakologie XVI/3;A Fleckenstein,1975
5. FLECKENSTEIN, A., FLECKENSTEIN-GRÜN, G.: Further studies on the neutralization of glycoside-induced contractures of coronary smooth muscle by Ca-antagonistic compounds (verapamil, D 600, prenylamine, nifedipine, fendiline or nitrites). Naunyn-Schmiedeberg’s Arch. Pharmacol. 287, Suppl. R 38 (1975).